What Is The Recurrence Score Result?
The Oncotype DX® Breast Cancer Assay analyzes the expression of 21 genes by RT-PCR to provide a Recurrence
Score result that is individualized to each patient. The Recurrence Score result predicts the magnitude of chemotherapy
benefit and indicates the 10-year risk of distant recurrence.1-2 The quantitative nature of RT-PCR* allows
for a continuous score as opposed to a binary result (low vs. high). This method is designed to provide you and your
patients with an individual risk score that can help inform your treatment plan.